← SynDRA
EDONENTAN
SynDRA canonical compound SYN0006014 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EDNRA | EDNRB |
|---|
| Mechanism of action | endothelin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Endothelin Receptor Antagonists
Cross-references
Synonyms
- Edonentan [INN]
- S5016F5ZH4
- EDONENTAN ANHYDROUS
- UNII-S5016F5ZH4
- UNII-2CCC8CH216
- compound 16a [PMID: 12502366]
- Edonentan [USAN:INN]
- BMS-207940 (monohydrate)
- compound 16a (PMID: 12502366)
- edonentanum
- RefChem:136296
- DTXCID6097811
- DTXCID70103552
- 2CCC8CH216
- BMS-207940-02
- Edonentan (USAN)
- EDONENTAN [USAN]
- Edonentan monohydrate
- BMS 207940
- BMS207940
- orb1697334
- orb2279117
- SCHEMBL1651069
- SCHEMBL29742313
- GTPL13015
- ORJRYNKVKJAJPY-UHFFFAOYSA-N
- BDBM50175502
- AKOS040751661
- HY-15402
- CS-0006251
- NS00124153
- T31605
- T77791
- BMS-207940, >=98% (HPLC)
- L001615
- edonentan anhydrous
- CS-0025074
Look up EDONENTAN in the interactive SynDRA portal →